TWI310380B - Process for the preparation of mesylates of piperazine derivatives - Google Patents

Process for the preparation of mesylates of piperazine derivatives Download PDF

Info

Publication number
TWI310380B
TWI310380B TW91102440A TW91102440A TWI310380B TW I310380 B TWI310380 B TW I310380B TW 91102440 A TW91102440 A TW 91102440A TW 91102440 A TW91102440 A TW 91102440A TW I310380 B TWI310380 B TW I310380B
Authority
TW
Taiwan
Prior art keywords
group
formula
compound
scope
patent application
Prior art date
Application number
TW91102440A
Other languages
Chinese (zh)
Inventor
P M Van Aar Marcel
J Schouten Stefanus
Zorgdrager Jan
C Heslinga Michiel
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Priority to TW91102440A priority Critical patent/TWI310380B/en
Application granted granted Critical
Publication of TWI310380B publication Critical patent/TWI310380B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

1310380 A7 B7 五、發明説明(i ) 技術範圍 本發明係關於一種製備六氫峨畊衍生物之甲續酸鹽之方 法。 、皿 發明背景 日本專利Να 3,〇44,383描述藉一種第一胺與一種取代之二 (羥乙基)胺之一種反應性酯反應可以獲得六氫吡啼衍生物。 此反應性酯衍生物是藉該取代之二(羥乙基)胺化合物與一種 具此通式R】SOrHal (其中Ri代表烷基或芳基,及榀丨是一個鹵 原子)之磺醯齒反應獲得。使用此方法獲得所需之六氫吡嗜 衍生物之氫氯酸或氫溴酸加成鹽。為獲得該對應甲磺酸鹽 該所得之鹽必須轉化成為自由鹼,藉使用甲磺酸鹽可以自 其製備所需之曱磺酸鹽。 兹已發現根據本發明之方法可以以一種經濟方式以高產 率及高純度直接獲得此類六氫吡啫衍生物之甲磺酸鹽。 詳細說明 本發明係關於一種用於製備具式⑴1310380 A7 B7 V. INSTRUCTION DESCRIPTION (i) Technical Field The present invention relates to a process for preparing a carbamate salt of a hexahydroquinone derivative. BACKGROUND OF THE INVENTION Japanese Patent Να 3, 〇 44, 383 describes that a hexahydropyridinium derivative can be obtained by reacting a first amine with a reactive ester of a substituted bis(hydroxyethyl)amine. The reactive ester derivative is a sulfonate tooth having the substituted bis(hydroxyethyl)amine compound and a compound of the formula R]SOrHal (wherein Ri represents an alkyl group or an aryl group, and hydrazine is a halogen atom) The reaction was obtained. Using this method, the desired hydrochloric acid or hydrobromic acid addition salt of the hexahydropyridyl derivative is obtained. To obtain the corresponding mesylate salt, the salt obtained must be converted to a free base from which the desired oxime sulfonate can be prepared by using the mesylate salt. It has been found that the mesylate salt of such a hexahydropyridinium derivative can be obtained directly in a high yield and high purity in an economical manner according to the process of the present invention. DETAILED DESCRIPTION The present invention relates to a method for preparing a formula (1)

(1) 之化合物之新穎方法,其係藉式(2) 之一種胺與式⑶A novel method of the compound of (1), which is an amine of formula (2) and formula (3)

(2) ~ 4 - (3) 1310380五、發明説明( A7 B7 足一種化合物及甲續酸肝反應’在其中式X代表-個基團具(2) ~ 4 - (3) 1310380 V. Description of the invention (A7 B7 is a compound and a reductive liver reaction) where X represents a group

其中 -&是氫或氟 -r2是氫,烷基(Mc),烷氧基(1_4(:)或一個橋氧基, -A代表一個5-7原子環之雜環基團其中有丨_3個雜原子自組 群Ο,N及S存在, -Y是甲基,乙基,以一或多個氟原子取代之乙基,環烷仏7 C)甲基選擇性以一或多個氟原子取代,或—個基團具式 (5) R3 ⑼ Z 其中Z是氫’苯基’苯基以1-3個取代基自組群經基卣,燒基 (1-4 C) ’奴氧基(1-4 C)或氰基取代,及r3是氫或丨_3個取代基自 組群鹵’羥基’烷基(1-4 C)或烷氧基(i_4 C)。 本發明宜是關於製備具式⑴之化合物之甲磺酸鹽其中X是 基團具式(6)Wherein -& is hydrogen or fluoro-r2 is hydrogen, alkyl (Mc), alkoxy (1_4 (:) or an oxo group, -A represents a heterocyclic group of a 5-7 atom ring which has a hydrazine _3 heteroatoms from the group Ο, N and S are present, -Y is a methyl group, an ethyl group, an ethyl group substituted with one or more fluorine atoms, a cycloalkane 7 C) methyl group selective to one or more Substituted by a fluorine atom, or a group having the formula (5) R3 (9) Z wherein Z is hydrogen 'phenyl'phenyl group with 1-3 substituents from the group via the base group, alkyl group (1-4 C) 'Nanoyl (1-4 C) or cyano substituted, and r3 is hydrogen or hydrazine - 3 substituents from the group of halo 'hydroxy' alkyl (1-4 C) or alkoxy (i_4 C). The present invention is preferably concerned with the preparation of a mesylate salt of the compound of the formula (1) wherein X is a group having the formula (6)

本紙張尺度適用中國菌家標準(CNS) A4規格(210 x 297公釐)This paper scale applies to the Chinese Mushroom Standard (CNS) A4 specification (210 x 297 mm)

裝 訂Binding

線 1310380 A7 B7 五、發明説明(3 ) 及γ有以上之意義。 本發明尤其是關於製備具式(1)之化合物之甲磺酸鹽其中X 是基團具式⑹,及Y代表間-苯基芊基,苄基或甲基。 根據本發明之方法該六氫吡畊環之合成及該甲磺酸鹽生 成是併合於一個單一步驟中其具重大優點。 一種具式(3)之化合物之反應性酯之生成藉將其與甲磺酸 肝反應宜是一種磁·諸如三乙胺之存在下進行。可以在一種 有機溶劑中於溫度介於0與150°C,宜是於回流溫度,進行此 反應。 適當的溶劑是例如單氯苯及甲乙酮。 具式(2)及(3)之起始化合物是已知之化合物或可以以如結 構上關連之已知化合物之相同方式製備。 具式(1)之化合物之甲續酸鹽是新穎化合物。此類化合物 之一些自由鹼,氫氯酸加成鹽及反-丁烯二酸鹽是已知者。 本發明也係關於具式(1)之化合物之新穎的甲磺酸鹽。 本發明尤其是關於具式(1)之化合物之甲磺酸鹽其中X是式 (6)之基團Line 1310380 A7 B7 V. Description of invention (3) and γ have the above meanings. More particularly, the present invention relates to the preparation of a mesylate salt of a compound of formula (1) wherein X is a group of formula (6), and Y represents m-phenylindenyl, benzyl or methyl. The synthesis of the hexahydropyrrole ring and the formation of the mesylate salt in accordance with the process of the present invention are significant advantages in a single step. The formation of a reactive ester of a compound of formula (3) is carried out by reacting it with methanesulfonic acid in the presence of a magnetic, such as triethylamine. The reaction can be carried out in an organic solvent at a temperature of from 0 to 150 ° C, preferably at reflux temperature. Suitable solvents are, for example, monochlorobenzene and methyl ethyl ketone. The starting compounds of formula (2) and (3) are known compounds or may be prepared in the same manner as known compounds which are structurally related. The carboxamide salt of the compound of formula (1) is a novel compound. Some of the free bases, hydrochloric acid addition salts and trans-butenedioates of such compounds are known. The invention also relates to novel mesylate salts of the compounds of formula (1). The invention particularly relates to a mesylate salt of a compound of formula (1) wherein X is a group of formula (6)

及Y有以上之意義。. 本發明更尤其是關於具式(1)之化合物之甲磺酸鹽其中X是 具式⑹之基團及Y代表間-苯基苄基,苄基或甲基。 本發明特別是關於具式(1)之化合物之甲磺酸鹽其中X是具 本紙張尺度適用中國國家標準(CNS) A4規格(210X297公釐) A7 B7 1310380 五、發明説明(4 ) 式(6)之基團及Y代表間-苯基苄基。 具式(1)之化合物之氫氯酸加成鹽,連同其引人注意之藥 理學性質是自WO 97/36893獲知。此已知之HC1-鹽之缺點是其 在水中之不良溶解度。在25°C於2’4’8及24小時後之溶解度 是介於0.18與0.2〇11^/1111。 茲已發現此化合物之甲磺酸鹽在水中之溶解度是約8-10倍 於該氫氯酸鹽者,是即1·7 mg/ml於25°C。此較高溶解度是具 重大重要性由於其造成該有效化合物之較佳的生物有效性。 實例說明 以次之例例證本發明。 姓 於氮氣下將27.14 g (lOOmmol)之二(羥乙基)間-苯基苄基胺 在150 ml之甲乙酮(MEK)中之溶液送入至一個裝設一支溫度 計,回流冷凝器及機械揽拌器之1000 ml圓底燒瓶中。在授拌 下於室溫溶解42.50 g (240 mmol)之曱磺酸酐於該溶液中。冷 卻該反應混合物至0-5°C,及在30-45分鐘期間一滴一滴加入 44.77 g (440 mmol)之三乙胺在50 ml之MEK中,保持該溫度在 10°C以下。加入另40 ml之MEK同時攪拌15分鐘於0-5。(:。在10-25分鐘期間一滴一滴加入23.08 g (240 mmol)之曱磺酸在30 ml 之MEK中同時維持溫度低於i〇°C。於以30 ml之MEK沖洗同時 攪拌15分鐘後,停止冷卻,及加入具式(2)其中X是式⑹之基 團之化合物15.01 g (100 mmol)。以130 ml之MEK沖洗該混合物 ,及加溫於20-251為時1小時。過濾該清澈溶液至另一個瓶 中及以60 ml之MEK洗蘇。加熱該混合物直至回流及約60 ml 本纸張尺度適用中國國家標準(CNS) A4規格(210X297公爱) 1310380 A7 B7 五、發明説明(5 ) 之MEK餾出。繼續回流為時8-24小時及加入140 ml之MEK。然 後餾出150 ml之水/MEK及冷卻該混合物至〇-5°C及於此溫度授 拌另2小時。過濾該產物,是即所需之甲磺酸鹽,以75 ml之 冷MEK (0-5°C )洗滌兩次,及於氮氣下於50°C (100 mbar)乾燥 。產量33.3 g ;熔化範圍263-275°C。 以相似方式製備具式(1)之化合物其中 1) X是式(6)之基團及Y是芊基 2) X是式(6)之基團及Y是甲基之甲磺酸鹽。 -8- 本紙張尺度適用中國國家標準(CNS) A4規格(210 X 297公釐)And Y has the above meaning. More particularly, the invention relates to a mesylate salt of a compound of formula (1) wherein X is a group of formula (6) and Y represents m-phenylbenzyl, benzyl or methyl. The invention relates in particular to the mesylate salt of the compound of formula (1) wherein X is of the paper size applicable to China National Standard (CNS) A4 specification (210X297 mm) A7 B7 1310380 V. Invention description (4) The group of 6) and Y represent m-phenylbenzyl. Hydrochloric acid addition salts of the compounds of formula (1), together with their attractive pharmacological properties, are known from WO 97/36893. A disadvantage of this known HCl-salt is its poor solubility in water. The solubility at 2 ° C 8 and after 24 hours at 25 ° C was between 0.18 and 0.2 〇 11 ^ / 1111. It has been found that the mesylate salt of this compound has a solubility in water of about 8-10 times that of the hydrochloride, i.e., 1·7 mg/ml at 25 °C. This higher solubility is of great importance as it results in better bioavailability of the active compound. EXAMPLES The invention is illustrated by the following examples. A solution of 27.14 g (100 mmol) of bis(hydroxyethyl) m-phenylbenzylamine in 150 ml of methyl ethyl ketone (MEK) was sent to a thermometer, reflux condenser and machinery under nitrogen. In a 1000 ml round bottom flask with a stirrer. 42.50 g (240 mmol) of hydrazine sulfonic anhydride was dissolved in the solution at room temperature with stirring. The reaction mixture was cooled to 0-5 ° C, and 44.77 g (440 mmol) of triethylamine was added dropwise in 50 ml of MEK during 30-45 minutes, keeping the temperature below 10 °C. Add another 40 ml of MEK while stirring for 15 minutes at 0-5. (:. Add 23.08 g (240 mmol) of sulfonic acid in 30 ml of MEK while maintaining the temperature below i〇 °C during 10-25 minutes. Rinse with 30 ml of MEK while stirring for 15 minutes. The cooling was stopped, and 15.01 g (100 mmol) of the compound of formula (2) wherein X is a group of formula (6) was added. The mixture was rinsed with 130 ml of MEK and warmed at 20-251 for 1 hour. The clear solution is washed into another bottle and washed with 60 ml of MEK. The mixture is heated until reflux and about 60 ml. The paper size is applicable to the Chinese National Standard (CNS) A4 specification (210X297 public) 1310380 A7 B7 V. Invention Description (5) MEK distillate. Continue to reflux for 8-24 hours and add 140 ml of MEK. Then distill 150 ml of water/MEK and cool the mixture to 〇-5 °C and mix at this temperature. 2 hours. The product was filtered to give the desired mesylate salt, washed twice with 75 ml cold MEK (0-5 ° C) and dried at 50 ° C (100 mbar) under nitrogen. g; melting range 263-275 ° C. A compound of formula (1) is prepared in a similar manner wherein 1) X is a group of formula (6) and Y is a fluorenyl group 2) X is formula (6) The group and Y are methyl methanesulfonate. -8- This paper scale applies to Chinese National Standard (CNS) A4 specification (210 X 297 mm)

Claims (1)

13103^0391102440 ------i- " 中文申請專利範圍隼換舟產^換頁 六、申請專利範1 1. 一種製備六氫吡畊衍生物之方法,特徵在於具式(ιΑ)化 合物之曱磺酸鹽13103^0391102440 ------i- " Chinese patent application scope 隼 change boat production ^ page change VI, application patent model 1 1. A method for preparing hexahydropyrrolidine derivatives, characterized by a compound of the formula (ι) Sulfonate 係藉式(2A)之一種胺An amine of formula (2A) 與式(3)之化合物Compound with formula (3) 及曱續酸酐反應而製備, 其中 Y是曱基,乙基,以一或多個氟原子取代之乙基,選擇性 本紙張尺度適用中國國家標準(CNS) A4规格(210X 297公爱) 1310380 A8 B8And the subsequent anhydride reaction is prepared, wherein Y is a mercapto group, an ethyl group, an ethyl group substituted by one or more fluorine atoms, and the selectivity of the paper scale is applicable to the Chinese National Standard (CNS) A4 specification (210X 297 public) 1310380 A8 B8 以或多個氟原子取代之環烧(3_7 C) ?基,或式⑶之基a ring-burning (3_7 C) group substituted with one or more fluorine atoms, or a group of formula (3) 其中Z疋氫’苯基’以卜3個選自經基、鹵烧基叫c) 烧氧基(1_4 C)或氰基之取代基取代之苯基,及是氣或 1 3個選自鹵、祕、烧基c)或烧氧基(卜4 c)之取代基, 。上述反應係於驗之存在下,於有機溶劑t,及於介於〇 °C及1 5 0 °C間之溫度下進行。 2.根據申請專利範園第1 夕士 靶固弟1項之方法,特徵在於該鹼係三乙 胺。 3. 根據申請專利範圍第1項之方法, 或甲乙_。, 該有機溶劑係單氯苯 4·根據申請專利範圍第w之方法,該溫度係迴流溫度。 5. 根據申請專利範圍第旧之方法,特徵在於製備其中γ代 表間-苯基爷基、爷基或甲基之式〇A)化合物之甲石黃酸鹽。 6. 根據申請專利範圍第!項之方法,特徵在於製備其中γ是 間-本基卞基之式(〗A)化合物之甲續酸鹽。 、 7. 根據申請專利範圍第i項之方法,特徵在於製備γ 苄基之式(1A)化合物之甲續酸鹽。 特徵在於製備其中Y是 根據申睛專利範圍第1項之方法, 甲基之式(1A)化合物之甲續酸鹽。 8. A BCD 1310380 六、申請專利範圍 9. 一種具式(1A)化合物之曱磺酸鹽,Wherein Z 疋 hydrogen 'phenyl' is a phenyl group substituted with 3 substituents selected from the group consisting of a transalkyl group, a halogenated group, a) an alkoxy group (1_4 C) or a cyano group, and a gas or 13 selected from the group consisting of a substituent of a halogen, a secret, a base c) or an alkoxy group (Bu 4 c). The above reaction is carried out in the presence of an organic solvent t and at a temperature between 〇 ° C and 150 ° C in the presence of the test. 2. The method according to claim 1 of the Patent Application No. 1 Xi Shi Targeting, characterized by the alkali triethylamine. 3. According to the method of claim 1 of the patent scope, or A and B. The organic solvent is monochlorobenzene. 4. According to the method of the patent application, the temperature is the reflux temperature. 5. The method according to the scope of the patent application, characterized in that a formazin is prepared in which a compound of the formula (A) wherein γ represents phenyl-phenyl, aryl or methyl. 6. According to the scope of the patent application! The method of the present invention is characterized in that a methyl orthoformate of the compound of the formula (A) wherein γ is a m-carbyl fluorenyl group is prepared. 7. A method according to the invention of claim i, characterized in that a methionate of the compound of the formula (1A) of the gamma benzyl group is prepared. Characterized by the preparation of a methyl sulphate of the compound of the formula (1A) wherein Y is a method according to the first aspect of the invention. 8. A BCD 1310380 VI. Scope of Application 9. A sulfonate of the compound of formula (1A), 其中該等符號具如申請專利範圍第1項所界定之意義。 10. 根據申請專利範圍第9項中之甲磺酸鹽,其中該等符號具 如申請專利範圍第2項中所界定之意義。 11. 根據申請專利範圍第10項之具式(1A)化合物之曱磺酸鹽, 其中Y是間-苯基苄基。 12. 根據申請專利範圍第10項之具式(1A)化合物之曱磺酸鹽, 其中Y是芊基。 13. 根據申請專利範圍第10項之具式(1A)化合物之曱磺酸鹽, 其中Y是曱基。 本紙張尺度適用中國國家標準(CNS) A4規格(210 χ 297公釐)Where such symbols have the meaning as defined in item 1 of the scope of the patent application. 10. The mesylate salt according to item 9 of the scope of the patent application, wherein the symbols have the meanings as defined in item 2 of the scope of the patent application. 11. The oxime sulfonate of the compound of formula (1A) according to claim 10, wherein Y is m-phenylbenzyl. 12. The oxime sulfonate of the compound of formula (1A) according to claim 10, wherein Y is a fluorenyl group. 13. The oxime sulfonate of the compound of formula (1A) according to claim 10, wherein Y is a fluorenyl group. This paper scale applies to the Chinese National Standard (CNS) A4 specification (210 297 297 mm)
TW91102440A 2002-02-08 2002-02-08 Process for the preparation of mesylates of piperazine derivatives TWI310380B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW91102440A TWI310380B (en) 2002-02-08 2002-02-08 Process for the preparation of mesylates of piperazine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW91102440A TWI310380B (en) 2002-02-08 2002-02-08 Process for the preparation of mesylates of piperazine derivatives

Publications (1)

Publication Number Publication Date
TWI310380B true TWI310380B (en) 2009-06-01

Family

ID=45072228

Family Applications (1)

Application Number Title Priority Date Filing Date
TW91102440A TWI310380B (en) 2002-02-08 2002-02-08 Process for the preparation of mesylates of piperazine derivatives

Country Status (1)

Country Link
TW (1) TWI310380B (en)

Similar Documents

Publication Publication Date Title
TW201033180A (en) Process for the preparation of piperazine compounds and hydrochloride salts thereof
RU2272036C2 (en) Method for preparing mesylate derivatives of piperazine
AU2002250962A1 (en) Process for the preparation of mesylates of piperazine derivatives
WO2003076374A1 (en) PROCESS FOR PRODUCING trans-4-AMINO-1-CYCLOHEXANECARBOXYLIC ACID DERIVATIVE
TWI310380B (en) Process for the preparation of mesylates of piperazine derivatives
CZ270193A3 (en) Novel amidoalkyl- and imidoalkyl piperazines
TW201144289A (en) Novel process for the preparation of piperazine compounds and hydrochloride salts thereof
TW201041855A (en) New process for preparing
JP2008503550A (en) Process for producing 2-amino-6-alkylamino-4,5,6,7-tetrahydrobenzothiazoles
JP2001097933A (en) Method for producing optically active 2- aminocyclohexanol derivative
JP4174093B2 (en) Method for producing triazole derivative halogen compound
JP2007502847A (en) Thiazolidinedione derivative and method for producing the compound
CA2682535A1 (en) Acetone solvate of phthaloyl amlodipine
JP2001288168A (en) Method for producing indole derivative
JP2014114221A (en) Method for producing benzimidazole derivative and intermediate thereof
JP2001278865A (en) Method for producing 4-aminoquinolines
JP2009514855A (en) Selective acylation of 4-substituted-1,3-phenylenediamine
JPH1160559A (en) Production of 3-pyrazolidinone compound
CN107108563A (en) Method for preparing some 1,5 2 substitution tetrazoliums
IE20000060A1 (en) Novel Process for Producing AMPA Antagonist Compounds
WO2001004088A1 (en) Process for the preparation of aniline derivatives
JP2002114750A (en) Method for producing aminobenzamidine compound
JP2001278864A (en) Method for producing 4-methoxyquinolines

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees